SELLAS Life Sciences Group Up Nearly 17%, on Track for Highest Close Since February 2023 -- Data Talk

Dow Jones2025-12-30

SELLAS Life Sciences Group, Inc. (SLS) is currently at $3.36, up $0.49 or 16.9%

 

--Would be highest close since Feb. 23, 2023, when it closed at $3.69

--On pace for largest percent increase since Jan. 31, 2025, when it rose 21.8%

--Currently up seven consecutive days; up 59% over this period

--Longest winning streak since Dec. 16, 2025, when it rose for seven straight trading days

--Best seven day stretch since the seven days ending Nov. 1, 2022, when it rose 89.37%

--Up 107.1% month-to-date; on pace for best month since Oct. 2022, when it rose 131.68%

--Up 222.6% year-to-date; on pace for best year since 2013, when it rose 224.18%

--Down 100% from its all-time closing high of $335363.30 on March 13, 2008

--Up 237.83% from 52 weeks ago (Dec. 30, 2024), when it closed at $0.99

--Would be a new 52-week closing high

--Up 264.67% from its 52-week closing low of $0.92 on Jan. 13, 2025

--Traded as high as $3.40; highest intraday level since Feb. 23, 2023, when it hit $3.85

--Up 18.47% at today's intraday high; largest intraday percent increase since Dec. 4, 2025, when it rose as much as 19.47%

 

All data as of 1:53:47 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 29, 2025 13:57 ET (18:57 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment